Which priority intervention should the nurse implement to prevent dehydration in a patient with ulcerative colitis experiencing diarrhea?

A) Encourage oral intake of electrolyte-rich solutions

B) Restrict fluid intake to reduce bowel activity

C) Administer diuretics to manage fluid overload

D) Provide a high-fiber diet to bulk stools

A 28-year-old female patient with a history of ulcerative colitis is admitted with abdominal cramping and mild tenderness in the lower left quadrant. Which of the following is the nurse's priority action to prevent dehydration?

C) Encourage oral fluid intake with electrolyte-rich solutions

A) Encourage increased dietary fiber intake

B) Administer prescribed oral mesalamine

C) Encourage oral fluid intake with electrolyte-rich solutions

D) Provide high-protein snacks between meals

Which of the following interventions is most important for the nurse to implement to ensure the patient's electrolyte balance remains stable?

B) Monitor the patient's intake and output closely.

A) Encourage the patient to continue a low-residue diet.

B) Monitor the patient's intake and output closely.

C) Administer an additional dose of mesalamine.

D) Instruct the patient to avoid all physical activity.

What is the primary reason for the patient's improvement in abdominal cramping as noted in the case?

A) Administration of mesalamine

C) Adherence to a low-residue diet

Which laboratory finding is most indicative of a positive response to treatment in a patient with ulcerative colitis?

C) C-reactive protein (CRP) level decrease from 10 mg/L to 6 mg/L

A) Hemoglobin level of 12.0 g/dL

B) White blood cell count of 6,800 cells/mm³

C) C-reactive protein (CRP) level decrease from 10 mg/L to 6 mg/L

D) Absence of blood in stool sample

A patient with ulcerative colitis is showing laboratory evidence of improvement, including decreased C-reactive protein levels and improved hemoglobin. What is the most important advice the nurse should give the patient regarding medication adherence?

B) Continue taking medication as prescribed, even if symptoms improve.

A) Stop taking medication once symptoms improve.

B) Continue taking medication as prescribed, even if symptoms improve.

C) Double the medication dose if symptoms return.

D) Take medication only when experiencing severe symptoms.

What is the primary purpose of assessing a patient's skin turgor?

C) To determine hydration status

A) To evaluate the presence of edema

B) To assess the patient's pain level

C) To determine hydration status

D) To check for signs of infection

Which laboratory finding indicates an improvement in the patient's condition with ulcerative colitis?

B) Decreased C-reactive protein (CRP) levels

A) Increased white blood cell count

B) Decreased C-reactive protein (CRP) levels

C) Elevated erythrocyte sedimentation rate (ESR)

A patient with ulcerative colitis has shown improvement in her laboratory markers, including decreased C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). What does this indicate about her current condition?

A) The patient's inflammation is reducing.

B) The patient is likely experiencing a new infection.

C) The patient is at increased risk for bleeding.

D) The patient's white blood cell count is elevated.

ulcerative colitis in acute setting - Nursing Case Study

Pathophysiology

• Primary mechanism: Ulcerative colitis is characterized by an inappropriate immune response where the immune system mistakenly attacks the lining of the colon, leading to inflammation and ulceration of the innermost layer of the colon, known as the mucosa.

• Secondary mechanism: This inflammation causes increased permeability of the intestinal barrier, allowing further infiltration of immune cells and leading to continuous cycles of inflammation and damage, resulting in symptoms such as diarrhea and abdominal pain.

• Key complication: In the acute setting, this inflammation can result in significant fluid and electrolyte loss, increasing the risk of dehydration and systemic complications if not managed promptly.

Patient Profile

Demographics:

28-year-old female, teacher

History:

• Key past medical history: Diagnosed with ulcerative colitis 2 years ago, mild intermittent asthma

• Current medications: Mesalamine, Albuterol inhaler as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased abdominal pain and diarrhea

• Key symptoms: Mild abdominal cramping, 4-5 episodes of non-bloody diarrhea per day, mild fatigue

• Vital signs: Blood pressure 118/76 mmHg, heart rate 78 bpm, respiratory rate 16 breaths per minute, temperature 98.6°F

Section 1

Initial Assessment Findings:

Upon admission to the acute care setting, the nursing team conducts a thorough initial assessment of the 28-year-old female patient with a history of ulcerative colitis. The patient appears alert and oriented, but demonstrates mild discomfort due to abdominal cramping. Her skin is warm and dry, with no signs of rash or lesions. During the abdominal examination, the nurse notes mild tenderness upon palpation in the lower left quadrant, consistent with her reported pain. Bowel sounds are active throughout all quadrants, and no guarding or rebound tenderness is observed, suggesting the absence of peritoneal irritation.

Laboratory results reveal a mild leukocytosis with a white blood cell count of 11,200/mm³, indicative of an inflammatory response, but no evidence of significant infection. The patient's hemoglobin level is slightly decreased at 11.5 g/dL, which may reflect minor anemia due to chronic blood loss or nutritional deficiencies often associated with ulcerative colitis. Electrolyte levels are within normal limits, though the patient exhibits a low-normal potassium level of 3.5 mEq/L, necessitating monitoring for potential hypokalemia due to ongoing diarrhea.

The nursing care plan prioritizes symptom management and prevention of dehydration. The patient is encouraged to maintain oral fluid intake, with an emphasis on electrolyte-rich solutions, while being monitored for signs of worsening dehydration or electrolyte imbalance. Education is provided on the importance of adhering to her prescribed medication regimen, particularly the mesalamine, to reduce inflammation and control symptoms. The care team also reviews dietary recommendations to minimize flare-ups, advising a low-residue diet to reduce bowel activity and ease symptoms. With the patient's condition currently stable, the focus remains on close monitoring and supportive care to prevent further complications.

Section 2

Response to Interventions:

Following the initial assessment and implementation of the care plan, the nursing team closely monitors the patient's response to the interventions. Over the next 24 hours, the patient demonstrates improved symptom control. Her abdominal cramping has lessened, with the patient rating her pain at a 3 out of 10, down from a 5 at admission. This improvement suggests that the prescribed mesalamine is effectively reducing intestinal inflammation. The patient continues to tolerate a low-residue diet and is diligently adhering to increased oral fluid intake, favoring electrolyte-rich beverages as recommended.

Vital signs are stable, with a blood pressure of 118/76 mmHg, heart rate of 78 beats per minute, respiratory rate of 16 breaths per minute, and an oral temperature of 98.4°F (36.9°C). These findings indicate hemodynamic stability and no signs of fever or significant distress. Regular monitoring of the patient's fluid status shows no signs of dehydration; mucous membranes are moist, and skin turgor remains normal. The patient's potassium level is re-evaluated and remains stable at 3.5 mEq/L, indicating that her electrolyte balance is being maintained effectively.

The care team notes the patient's positive response to the current treatment regimen and continues to emphasize the importance of medication adherence and dietary management. They plan to reassess the patient's laboratory values in the next 48 hours to ensure continued stability. The patient's progress is encouraging, and the focus remains on maintaining her stable condition while preparing for discharge planning, which will include reinforcing education on recognizing early signs of a flare-up and when to seek medical attention.

Section 3

New Diagnostic Results:

As the patient continues her recovery in the acute care setting, the healthcare team receives new laboratory results that provide further insight into her condition. A follow-up complete blood count (CBC) reveals a slight improvement in her hemoglobin levels, now at 12.0 g/dL, up from 11.5 g/dL at admission. Her white blood cell count remains within normal limits at 6,800 cells/mm³, indicating no significant infection or inflammation beyond what is expected with her condition. C-reactive protein (CRP) levels have decreased from 10 mg/L to 6 mg/L, suggesting a positive response to the anti-inflammatory treatment.

Additionally, the recent stool sample analysis confirms the absence of blood and a reduction in leukocytes, further indicating that the intestinal lining is healing. These results, alongside her stable vital signs and improved symptom control, suggest that the current treatment plan is effectively managing her ulcerative colitis. The nursing team uses these findings to reinforce the importance of adherence to her medication regimen and dietary recommendations, as they are clearly contributing to her recovery.

The healthcare team discusses these results with the patient, highlighting the significance of the improvements and educating her on the importance of monitoring symptoms and adhering to prescribed therapies. This education is crucial as the team begins to prepare the patient for potential discharge. They emphasize the need for regular follow-up visits and the importance of recognizing early signs of a flare-up, such as increased abdominal pain or changes in bowel habits, to ensure prompt intervention and prevent complications. The focus remains on empowering the patient with the knowledge and tools needed to manage her condition effectively at home.

Section 4

As the patient progresses through her recovery, the nursing team conducts a routine follow-up assessment to evaluate her current status. Upon entering the room, the nurse notes that the patient is resting comfortably, exhibiting no signs of distress. Her vital signs remain stable: blood pressure at 118/76 mmHg, heart rate at 72 beats per minute, respiratory rate at 16 breaths per minute, and temperature at 98.6°F. During the physical examination, the nurse observes that the patient's abdomen is soft and non-tender with normal bowel sounds, and the patient reports only mild, intermittent abdominal discomfort, which is significantly improved from her initial presentation.

The nurse assesses the patient's hydration status, noting that her mucous membranes are moist and her skin turgor is normal, indicating adequate hydration. The patient expresses a good appetite and has been adhering to a low-residue diet as recommended, which she reports has helped reduce her symptoms. The patient shares that her bowel movements have become more regular, with no recent episodes of diarrhea, and she remains free of rectal bleeding since her admission.

These positive assessment findings reinforce the effectiveness of the current treatment plan, which includes mesalamine therapy and dietary modifications. The nursing team takes this opportunity to reinforce patient education, emphasizing the importance of maintaining her dietary restrictions and medication adherence to sustain her progress. They also discuss the patient's upcoming discharge plan, ensuring she understands the significance of regular monitoring and follow-up appointments to promptly address any potential flare-ups or complications. This proactive approach aims to empower the patient with the knowledge needed to manage her condition effectively at home, ultimately leading to a smooth transition from the acute care setting.

Section 5

As the patient continues her recovery from ulcerative colitis in the acute setting, the nursing team receives new diagnostic results that provide insight into her current condition. Recent laboratory tests show that her inflammatory markers, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), have decreased significantly, indicating a reduction in inflammation. Her complete blood count (CBC) reveals a stable white blood cell count, suggesting that any systemic response to inflammation is well under control. Additionally, her hemoglobin and hematocrit levels remain within normal limits, confirming that she has not experienced any recent bleeding episodes, which aligns with her clinical presentation.

The nurse reviews these results with the patient, explaining that the improvement in her laboratory markers supports the observed clinical progress. This positive feedback reassures the patient that her adherence to the treatment plan, particularly the mesalamine therapy and dietary modifications, is effectively managing her condition. The nurse takes this opportunity to further educate the patient on the importance of continuing her prescribed regimen and reminds her of the potential triggers that could lead to flare-ups, such as stress, dietary indiscretion, and non-adherence to medication.

These findings and discussions pave the way for the next steps in the patient's journey, focusing on her transition from the hospital to home. The nursing team collaborates with the patient to reinforce the discharge plan, which includes instructions for monitoring symptoms at home, recognizing early signs of a potential relapse, and scheduling follow-up appointments with her gastroenterologist. By ensuring the patient is well-informed and confident in managing her condition, the healthcare team aims to facilitate a smooth transition and promote long-term well-being.